Table 1.
Variables associated with 30 day mortality
| Variable | Alive (N = 2328) | Died (N = 279) | P |
|---|---|---|---|
| Age >66 years, n (%) | 963 (41.5) | 251 (90) | 0.001 |
| Male, n (%) | 1339 (57.8) | 167 (59.9) | 0.522 |
| Hypertension, n (%) | 998 (42.9) | 196 (80.3) | 0.001 |
| Diabetes mellitus, n (%) | 423 (18.2) | 84 (30.1) | 0.001 |
| Chronic heart disease, n (%) | 487 (20.9) | 150 (53.8) | 0.001 |
| Chronic pulmonary disease, n (%) | 541 (23.2) | 89 (31.9) | 0.002 |
| Chronic renal failure, n (%) | 201 (8.6) | 97 (34.8) | 0.001 |
| Liver disease, n (%) | 156 (6.7) | 17 (6.1) | 0.799 |
| Haematological malignancy, n (%) | 136 (5.8) | 32 (11.5) | 0.001 |
| Solid neoplasm, n (%) | 306 (13.1) | 65 (23.3) | 0.001 |
| Solid organ transplantation, n (%) | 45 (1.9) | 9 (3.2) | 0.177 |
| HIV, n (%) | 34 (1.5) | 5 (1.8) | 0.602 |
| Pre-admission duration of symptoms, n (%) | |||
| ≤3 days of symptoms | 464 (19.9) | 113 (40.5) | 0.001 |
| 4–6 days of symptoms | 629 (27) | 67 (24) | 0.001 |
| >6 days of symptoms | 1235 (53) | 99 (35.5) | 0.001 |
| Temperature >37°C (N = 2554), n (%) | 1184 (51.4) | 104 (41.4) | 0.003 |
| Respiratory rate >21 bpm at day 1–2 (N = 2128), n (%) | 891 (46.7) | 168 (76.7) | 0.001 |
| Oxygen saturation ≤94% (N = 2546), n (%) | 1203 (52.4) | 188 (74.9) | 0.001 |
| Creatinine >0.92 mg/dL (N = 2593), n (%) | 1017 (43.9) | 211 (77) | 0.001 |
| Lactate dehydrogenase >305 U/L (N = 2524), n (%) | 1096 (48.4) | 171 (66.3) | 0.001 |
| Lymphocyte count ≤800 cells/mm3 (N = 2593), n (%) | 1127 (48.6) | 182 (66.4) | 0.001 |
| C-reactive protein >7.52 mg/dL (N = 2590), n (%) | 1127 (48.7) | 198 (72.3) | 0.001 |
| Remdesivir, n (%) | 419 (18) | 19 (6.8) | 0.001 |
| Tocilizumab within 3 days, n (%) | 140 (6) | 18 (6.5) | 0.790 |
| Corticosteroids within 3 days, n (%) | 264 (11.3) | 27 (9.7) | 0.481 |
| ICU admission, n (%) | 415 (17.8) | 61 (21.9) | 0.101 |
| Invasive mechanical ventilation, n (%) | 214 (9.2) | 50 (17.9) | 0.001 |